Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Cardner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|September 13, 2019
Inferring signalling dynamics by integrating interventional with observational dataMathias Cardner, Nathalie Meyer-Schaller, Gerhard Christofori, et al.
Scientific Reports|March 9, 2022
Discovery of antimicrobials by massively parallelized growth assays (Me<sup>x</sup>)Philipp Koch, Steven Schmitt, Mathias Cardner, et al.
BMC Bioinformatics|September 30, 2023
Predicting tumour content of liquid biopsies from cell-free DNAMathias Cardner, Francesco Marass, Erika Gedvilaite, et al.
Developmental Cell|February 5, 2019
A Hierarchical Regulatory Landscape during the Multiple Stages of EMTNathalie Meyer-Schaller, Mathias Cardner, Maren Diepenbruck, et al.
RMD Open|June 15, 2023
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritisMathias Cardner, Danny Tuckwell, Anna Kostikova, et al.
Respiratory Research|July 3, 2025
ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthmaDavinder Paul Singh Dosanjh, Erika Darrah, Tina Jellesmark Jensen, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2026
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis - STEPIn Mechanistic Sub-study resultsJohann E Gudjonsson, Katharina Bier, Swann Gaulis, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trialSarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
JCI Insight|December 13, 2019
Structure-function relationships of HDL in diabetes and coronary heart diseaseMathias Cardner, Mustafa Yalcinkaya, Sandra Goetze, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|September 13, 2019
Inferring signalling dynamics by integrating interventional with observational dataMathias Cardner, Nathalie Meyer-Schaller, Gerhard Christofori, et al.
Scientific Reports|March 9, 2022
Discovery of antimicrobials by massively parallelized growth assays (Me<sup>x</sup>)Philipp Koch, Steven Schmitt, Mathias Cardner, et al.
BMC Bioinformatics|September 30, 2023
Predicting tumour content of liquid biopsies from cell-free DNAMathias Cardner, Francesco Marass, Erika Gedvilaite, et al.
Developmental Cell|February 5, 2019
A Hierarchical Regulatory Landscape during the Multiple Stages of EMTNathalie Meyer-Schaller, Mathias Cardner, Maren Diepenbruck, et al.
RMD Open|June 15, 2023
Analysis of serum proteomics data identifies a quantitative association between beta-defensin 2 at baseline and clinical response to IL-17 blockade in psoriatic arthritisMathias Cardner, Danny Tuckwell, Anna Kostikova, et al.
Respiratory Research|July 3, 2025
ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthmaDavinder Paul Singh Dosanjh, Erika Darrah, Tina Jellesmark Jensen, et al.
The Journal of Allergy and Clinical Immunology|May 26, 2026
Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis - STEPIn Mechanistic Sub-study resultsJohann E Gudjonsson, Katharina Bier, Swann Gaulis, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trialSarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
JCI Insight|December 13, 2019
Structure-function relationships of HDL in diabetes and coronary heart diseaseMathias Cardner, Mustafa Yalcinkaya, Sandra Goetze, et al.
Pageof 1